Access the full text.
Sign up today, get DeepDyve free for 14 days.
N. Freedman, J. Everhart, K. Lindsay, M. Ghany, T. Curto, M. Shiffman, William Lee, A. Lok, A. Bisceglie, H. Bonkovsky, J. Hoefs, J. Dienstag, C. Morishima, C. Abnet, R. Sinha (2009)
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis CHepatology, 50
P. Halfon, S. Locarnini (2011)
Hepatitis C virus resistance to protease inhibitors.Journal of hepatology, 55 1
R. Zeitlin, Sagar Patel, S. Burgess, G. Arendash, V. Echeverria (2011)
Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic miceBrain Research, 1417
J. Okano, T. Nagahara, Kazuya Matsumoto, Y. Murawaki (2008)
Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway.Basic & clinical pharmacology & toxicology, 102 6
M. Hoff, A. Moorman, W. Lamers (1992)
Electroporation in 'intracellular' buffer increases cell survival.Nucleic acids research, 20 11
Ying-Ting Lin, Yu‐Hsuan Wu, Chin-kai Tseng, Chun‐Kuang Lin, Wei‐Chun Chen, Y. Hsu, Jin-Ching Lee (2013)
Green Tea Phenolic Epicatechins Inhibit Hepatitis C Virus Replication via Cycloxygenase-2 and Attenuate Virus-Induced InflammationPLoS ONE, 8
Donna Tscherne, Christopher Jones, Matthew Evans, Brett Lindenbach, J. McKeating, Charles Rice (2006)
Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered EntryJournal of Virology, 80
R. Sinha, B. Farah, B. Singh, M. Siddique, Ying Li, Yajun Wu, O. Ilkayeva, J. Gooding, J. Ching, Jin Zhou, Laura Martínez, Sherwin Xie, B. Bay, S. Summers, C. Newgard, P. Yen (2014)
Caffeine stimulates hepatic lipid metabolism by the autophagy‐lysosomal pathway in miceHepatology, 59
N. Kang, K. Lee, B. Kim, A. Bode, Hyo-Jeong Lee, Y. Heo, L. Boardman, P. Limburg, Hyong Lee, Z. Dong (2011)
Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK.Carcinogenesis, 32 6
T. Okamoto, Y. Nishimura, T. Ichimura, Kensuke Suzuki, T. Miyamura, Tetsuro Suzuki, K. Moriishi, Y. Matsuura (2006)
Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90The EMBO Journal, 25
B. Lindenbach, M. Evans, A. Syder, B. Wölk, T. Tellinghuisen, Christopher Liu, T. Maruyama, R. Hynes, D. Burton, J. McKeating, C. Rice (2005)
Complete Replication of Hepatitis C Virus in Cell CultureScience, 309
Pin-Zhen Lu, Ching-Yu Lai, W. Chan (2008)
Caffeine Induces Cell Death via Activation of Apoptotic Signal and Inactivation of Survival Signal in Human OsteoblastsInternational Journal of Molecular Sciences, 9
Yutaka Amako, G. Syed, A. Siddiqui (2011)
Protein Kinase D Negatively Regulates Hepatitis C Virus Secretion through Phosphorylation of Oxysterol-binding Protein and Ceramide Transfer Protein*The Journal of Biological Chemistry, 286
Qian Ding, Jiaolin Bao, Wenwen Zhao, Yangyang Hu, Jin-jian Lu, Xiuping Chen (2015)
Natural autophagy regulators in cancer therapy: a reviewPhytochemistry Reviews, 14
Zhimin Tao, Eyone Jones, J. Goodisman, A. Souid (2008)
Quantitative measure of cytotoxicity of anticancer drugs and other agents.Analytical biochemistry, 381 1
A. Modi, J. Feld, Y. Park, D. Kleiner, J. Everhart, T. Liang, J. Hoofnagle (2010)
Increased caffeine consumption is associated with reduced hepatic fibrosisHepatology, 51
Tara Kieffer, A. Kwong, G. Picchio (2010)
Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs).The Journal of antimicrobial chemotherapy, 65 2
Antimicrob Agents Chemother
R. Beran, Ruchi Sharma, A. Corsa, Ya-Wen Tian, Justin Golde, G. Lundgaard, W. Delaney, W. Zhong, A. Greenstein (2012)
Cellular Growth Kinetics Distinguish a Cyclophilin Inhibitor from an HSP90 Inhibitor as a Selective Inhibitor of Hepatitis C VirusPLoS ONE, 7
Zhigang Yi, Tingting Pan, Xianfang Wu, Wuhui Song, Shanshan Wang, Yan Xu, C. Rice, M. MacDonald, Zhenghong Yuan (2011)
Hepatitis C Virus Co-Opts Ras-GTPase-Activating Protein-Binding Protein 1 for Its Genome ReplicationJournal of Virology, 85
C-H Kang, R. Jayasooriya, M. Dilshara, Yung-Hyun Choi, Y. Jeong, N. Kim, Gi-Young Kim (2012)
Caffeine suppresses lipopolysaccharide-stimulated BV2 microglial cells by suppressing Akt-mediated NF-κB activation and ERK phosphorylation.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 50 12
D. Lavanchy (2011)
Evolving epidemiology of hepatitis C virus.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 17 2
M. Dreux, P. Gastaminza, S. Wieland, F. Chisari (2009)
The autophagy machinery is required to initiate hepatitis C virus replicationProceedings of the National Academy of Sciences, 106
Y. Eom, Mi Kim, S. Park, Mi Goo, Hyuk Kwon, S. Sohn, Wook Kim, G. Yoon, K. Choi (2005)
Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotypeOncogene, 24
D. Wyles, Kelly Kaihara, B. Korba, R. Schooley, J. Beadle, K. Hostetler (2009)
The Octadecyloxyethyl Ester of (S)-9-[3-Hydroxy-2-(Phosphonomethoxy) Propyl]Adenine Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication in Genotype 1A, 1B, and 2A RepliconsAntimicrobial Agents and Chemotherapy, 53
B. Mohl, P. Tedbury, Stephen Griffin, M. Harris (2012)
Hepatitis C Virus-Induced Autophagy Is Independent of the Unfolded Protein ResponseJournal of Virology, 86
I. Cadden, N. Partovi, E. Yoshida (2007)
Review article: possible beneficial effects of coffee on liver disease and functionAlimentary Pharmacology & Therapeutics, 26
Jin-Ching Lee, Wei‐Chun Chen, Shou-Fang Wu, Chin-kai Tseng, C. Chiou, Fangyuan Chang, S. Hsu, Y. Wu (2011)
Anti-hepatitis C virus activity of Acacia confusa extract via suppressing cyclooxygenase-2.Antiviral research, 89 1
Y. Kawano, M. Nagata, Takafumi Kohno, Akihiro Ichimiya, T. Iwakiri, M. Okumura, K. Arimori (2012)
Caffeine increases the antitumor effect of Cisplatin in human hepatocellular carcinoma cells.Biological & pharmaceutical bulletin, 35 3
J. Vermehren, C. Sarrazin (2012)
The role of resistance in HCV treatment.Best practice & research. Clinical gastroenterology, 26 4
J. Pawlotsky (2012)
New Antiviral Agents for Hepatitis CF1000 Biology Reports, 4
Jin Zhong, P. Gastaminza, G. Cheng, S. Kapadia, Takanobu Kato, D. Burton, S. Wieland, S. Uprichard, T. Wakita, F. Chisari (2005)
Robust hepatitis C virus infection in vitro.Proceedings of the National Academy of Sciences of the United States of America, 102 26
S. Gretton, Mair Hughes, M. Harris (2010)
Hepatitis C virus RNA replication is regulated by Ras-Erk signalling.The Journal of general virology, 91 Pt 3
Sunitha Kumari, H. Mendoza-Alvarez, R. Alvarez‐Gonzalez (1998)
Functional interactions of p53 with poly(ADP-ribose) polymerase (PARP) during apoptosis following DNA damage: covalent poly(ADP-ribosyl)ation of p53 by exogenous PARP and noncovalent binding of p53 to the M(r) 85,000 proteolytic fragment.Cancer research, 58 22
Shin-ichiro Nakagawa, T. Umehara, C. Matsuda, S. Kuge, M. Sudoh, M. Kohara (2007)
Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice.Biochemical and biophysical research communications, 353 4
J. Hoofnagle (2002)
Course and outcome of hepatitis CHepatology, 36
S. Chevaliez, J. Pawlotsky (2007)
Hepatitis C virus: virology, diagnosis and management of antiviral therapy.World journal of gastroenterology, 13 17
Q. Choo, G. Kuo, A. Weiner, L. Overby, D. Bradley, M. Houghton (1989)
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.Science, 244 4902
C. Costentin, F. Roudot-thoraval, E. Zafrani, F. Medkour, J. Pawlotsky, A. Mallat, C. Hézode (2011)
Association of caffeine intake and histological features of chronic hepatitis C.Journal of hepatology, 54 6
C. Ruhl, J. Everhart (2005)
Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States.Gastroenterology, 128 1
Caffeine inhibits hepatitis 407
Hepatitis C is considered the major cause of cirrhosis and hepatocellular carcinoma. Conventional treatment is not effective against some hepatitis C virus (HCV) genotypes; therefore, new treatments are needed. Coffee and, more recently, caffeine, have been found to have a beneficial effect in several disorders of the liver, including those manifesting abnormal liver biochemistry, cirrhosis and hepatocellular carcinoma. Caffeine acts directly by delaying fibrosis, thereby improving the function of liver cellular pathways and interfering with pathways used by the HCV replication cycle. In the current study, the direct relationship between caffeine and viral replication was evaluated. The Huh-7.5 cell line was used for transient infections with FL-J6/JFH-5′C19Rluc2AUbi and to establish a cell line stably expressing SGR-Feo JFH-1. Caffeine efficiently inhibited HCV replication in a dose-dependent manner at non-cytotoxic concentrations and demonstrated an IC 50 value of 0.7263 mM after 48 h of incubation. These data demonstrate that caffeine may be an important new agent for anti-HCV therapies due to its efficient inhibition of HCV replication at non-toxic concentrations.
Archives of Virology – Springer Journals
Published: Feb 1, 2015
Access the full text.
Sign up today, get DeepDyve free for 14 days.